Previous studies revealed a pro-oncogenic role of PIGR in hepatocellular cancer by activating Src family tyrosine kinase (Yes) and MEK/ERK signaling (Yue et al., 2017), while PIGR in breast cancer was rarely reported. The gene discussed is MAP2K7; the disease is breast carcinoma.